These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32852563)

  • 1. Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous Immunoglobulin.
    Tarnowietzki E; Peters T; Kraus L; Schmidt E; Scharffetter-Kochanek K
    Acta Derm Venereol; 2020 Oct; 100(17):adv00301. PubMed ID: 32852563
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-laminin 332 mucous membrane pemphigoid in a young woman treated with rituximab.
    Gitin A; Porta AD; Bisbee E; Braunlich K; Motaparthi K
    Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chinese case of concurrent anti-laminin γ1 pemphigoid and anti-laminin 332-type mucous membrane pemphigoid.
    Liu W; Sun X; Gao Y; Li H; Shi L; Cheng L; Zhou Z; Li X; Qian H
    J Dermatol; 2023 Feb; 50(2):e69-e71. PubMed ID: 35811504
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemphigoid without mucous involvement showing IgG antibodies to the β3 subunit of laminin-332.
    Miyahara H; Oya K; Kubota N; Ishii N; Nomura T
    J Dtsch Dermatol Ges; 2024 Apr; 22(4):570-573. PubMed ID: 38326082
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.
    Rashid H; Meijer JM; Bolling MC; Horváth B
    Br J Dermatol; 2022 Apr; 186(4):721-723. PubMed ID: 34747507
    [No Abstract]   [Full Text] [Related]  

  • 6. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
    Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome and safety of rituximab therapy for pemphigoid diseases.
    Tovanabutra N; Payne AS
    J Am Acad Dermatol; 2020 May; 82(5):1237-1239. PubMed ID: 31738960
    [No Abstract]   [Full Text] [Related]  

  • 8. Localized genital mucous membrane pemphigoid of the penis: Notes on two cases.
    Joly E; Seta V; Plantier F; Dupin N; Chanal J
    Ann Dermatol Venereol; 2021 Sep; 148(3):202-203. PubMed ID: 34183172
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of rituximab in the treatment of mucous membrane pemphigoid: An analytic review.
    Farooq MM; Miloslavsky EM; Konikov N; Ahmed AR
    Autoimmun Rev; 2022 Aug; 21(8):103119. PubMed ID: 35688385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cicatricial pemphigoid, mucous membrane pemphigoid].
    Doffoel-Hantz V; Robert PY; Bédane C
    Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and 2019.
    Bamberger F; König IR; Gola D; Zillikens D; Sadik CD
    Front Immunol; 2023; 14():1180150. PubMed ID: 37143653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M mucous membrane pemphigoid.
    Yilmaz K; Hammers CM; Boch K; Zillikens D; Shimanovich I; Schmidt E
    J Dtsch Dermatol Ges; 2023 Mar; 21(3):285-287. PubMed ID: 36772920
    [No Abstract]   [Full Text] [Related]  

  • 13. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
    Buonavoglia A; Leone P; Dammacco R; Di Lernia G; Petruzzi M; Bonamonte D; Vacca A; Racanelli V; Dammacco F
    Autoimmun Rev; 2019 Apr; 18(4):349-358. PubMed ID: 30738958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for oral mucous membrane (cicatricial) pemphigoid: experience at an academic dermatology outpatient clinic.
    Hrin ML; Williams JA; Bowers NL; Ahn CS; Strowd LC
    J Am Acad Dermatol; 2022 Dec; 87(6):1431-1433. PubMed ID: 35948167
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-Laminin 332-Type Mucous Membrane Pemphigoid.
    Shi L; Li X; Qian H
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP4-inhibitor-associated oral mucous membrane pemphigoid.
    Thermos G; Katsoulas N; Vilos G; I Tosios K
    Oral Dis; 2023 Jul; 29(5):2321-2323. PubMed ID: 35491436
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
    Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
    Front Immunol; 2018; 9():248. PubMed ID: 29520266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of mucous membrane pemphigoid with anti-BP230 autoantibodies alone.
    Yoshimoto N; Ujiie I; Inamura E; Natsuga K; Nishie W; Shimizu H; Ujiie H
    Int J Dermatol; 2021 Mar; 60(3):e92-e94. PubMed ID: 32970829
    [No Abstract]   [Full Text] [Related]  

  • 19. Multifaceted mucous membrane pemphigoid.
    Heymann WR
    J Am Acad Dermatol; 2022 Jul; 87(1):46-47. PubMed ID: 35513180
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
    Bohelay G; Alexandre M; Le Roux-Villet C; Sitbon I; Doan S; Soued I; Shourick J; Rousset L; Mellottee B; Heller M; Lièvre N; Zumelzu C; Morin F; Grootenboer-Mignot S; Gabison E; Caux F; Prost-Squarcioni C; Musette P
    Front Immunol; 2022; 13():915205. PubMed ID: 35844526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.